Is US Preparing For A Quademic 2025?

Updated Jan 15, 2025 | 03:10 PM IST

SummaryQuademic 2025: It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
Is US preparing for a quademic?

Credits: Canva

Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.

The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.

Is US able to cope with Quademic 2025?

The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.

ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are

What are these quademic infections?

Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.

Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.

The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.

RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.

However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.

Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.

For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.

End of Article

WHO Says Suspected Hantavirus Killed 3 on Cruise Ship: Symptoms, Risks, and Prevention

Updated May 4, 2026 | 09:39 AM IST

SummaryHantavirus is a rare rodent-borne virus that may spread between people and can lead to severe respiratory illness, requiring careful patient monitoring, support, and response, according to the WHO.
WHO Says Suspected Hantavirus Killed 3 on Cruise Ship: Symptoms, Risks, and Prevention

Credit: AI generated image

The World Health Organization (WHO) said on May 3 that three people who died aboard a cruise ship in the Atlantic Ocean were suspected to have been infected with hantavirus. The rodent-borne virus can cause severe and sometimes fatal respiratory illness.

"To date, one case of hantavirus infection has been laboratory confirmed, and there are five additional suspected cases," the organization said in a post on social media platform X.

"Of the six affected individuals, three have died, and one is currently in intensive care in South Africa," it added.

In a statement provided to USA TODAY, Netherlands-based expedition cruise operator Oceanwide Expeditions said it was addressing a "serious medical situation" on board m/v Hondius. The ship was en route from Argentina to Cape Verde, an island nation off Africa's west coast.

What Is Hantavirus?

According to the Centers for Disease Control and Prevention (CDC), hantaviruses are a family of viruses that can cause severe illnesses and even death. The hantavirus is primarily spread by rodents through

  • exposure to their urine,
  • droppings,
  • saliva,
  • less commonly through a scratch or bite.
"While rare, hantavirus may spread between people, and can lead to severe respiratory illness and requires careful patient monitoring, support, and response," according to the WHO.

The CDC notes that hantaviruses are capable of causing diseases like hantavirus pulmonary syndrome or HPS and hemorrhagic fever with renal syndrome or HERS.

It can infect and cause serious diseases in people. It has mainly two syndromes. One is found in the Western Hemisphere, including in the US, which can cause HPS.

The most common hantavirus that causes HPS in the US is spread by the deer mouse. HERS is a group that is similar to illnesses caused by hantaviruses and is found mostly in Asia and Europe. There's another type, called the Seoul virus, which is a type of hantavirus that causes HERS and is found worldwide, including in the US.

The WHO did not specify the type of hantavirus or syndrome in the cruise incident, but did mention respiratory risks.

Hantavirus: What Are The Common Symptoms?

According to the CDC, symptoms can appear one to eight weeks after exposure, initially presenting fatigue, fever, and muscle aches. As the disease progresses, it can cause coughing, shortness of breath, and chest tightness as fluid accumulates in the lungs.

The CDC reports that about one-third of individuals who develop respiratory symptoms from the disease may not survive.

Despite extensive research, many questions remain unanswered, including why some cases are mild while others become severe and how antibodies develop. She and other researchers have been tracking patients over extended periods, hoping to uncover potential treatments.

Also read: India Concerned Over Measles Outbreak, Action Underway: Dr N K Arora| Exclusive

Hantavirus: How Can You Reduce Your Risk?

You can reduce your risk by eliminating and minimizing your contact with rodents in your home, workplace, or campsite. The best way is to seal holes and gaps in your home or garage and keep the rodents from entering your home. You can also place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food that could attract rodents.

Hantavirus: How Does The Diagnosis Work?

CDC notes that the diagnosis in a person who has been infected for less than 72 hours is difficult. If the initial test is done before the virus can be found, then a repeat test is required after 72 hours whenever the symptoms start to show up. Early symptoms, as mentioned above, like fever, headache, muscle aches, nausea, and fatigue, could also be easily confused with influenza, thus a test is extremely important.

End of Article

CDC Flags Surge in US Tuberculosis Outbreaks, Cases Double Since 2017

Updated May 3, 2026 | 12:00 AM IST

Summary​The large outbreaks accounted for 1,092 of the 61,993 cases reported between 2017 and 2023. Two-thirds of large outbreaks occurred within family and social networks. Persons with TB in large outbreaks reported substance use, homelessness, and incarceration more often than did other persons with TB.
CDC Flags Surge in US Tuberculosis Outbreaks, Cases Double Since 2017

Credit: AI generated image

The US has witnessed 50 large tuberculosis outbreaks (defined as 10 or more related cases in three years) across 23 states from 2017 through 2023, according to a new report by the Centers for Disease Control and Prevention.

The latest Morbidity and Mortality Weekly Report showed that the numbers, primarily involving U.S.-born persons, have more than doubled in recent years and disproportionately affected socially and economically vulnerable populations.

The outbreaks accounted for 1,092 of the 61,993 cases reported during the period. Two-thirds of large outbreaks occurred within family and social networks. Persons with TB in large outbreaks reported substance use, homelessness, and incarceration more often than did other persons with TB.

The numbers also show a sharp increase from the 24 identified from 2014 to 2016, suggesting that transmission within family and social networks is an ongoing issue, despite the US having one of the lowest TB incidence rates in the world.

“Approximately 80 per cent of large outbreak-related cases occurred among US-born persons. The identification of large outbreaks in approximately one-half of US states, including many with TB incidence below the national average, indicates that maintaining public health capacity for TB outbreak prevention, detection, and response remains critical even in jurisdictions with low TB incidence,” said corresponding author Kala M. Raz, from the Division of Tuberculosis Elimination, CDC

What Are The Key Finding?

Notably, the report showed that people involved in the large outbreaks differed from other TB patients. The differences include:

  • Nearly 80 per cent of cases were among US-born people, compared to 26 per cent in non-outbreak TB cases
  • Substance use was more common (27 per cent vs 12 per cent)
  • Around 9 per cent were homeless, compared to 5 per cent in non-outbreak cases
  • Over 11 per cent had been incarcerated, vs 3 per cent in non-outbreak TB
  • More cases were seen in children under 15 (15 per cent vs 3 per cent)
  • Higher share among adults aged 25–44 (40 per cent vs 29 per cent)
  • Fewer cases in adults 65+ (8 per cent vs 26 per cent)
  • About two-thirds of outbreaks spread within families or social circles
  • Around one-quarter occurred in group settings like workplaces, prisons, care homes, universities, and shelters
  • Outbreaks were reported in 23 states, including those with lower TB rates
  • Large outbreaks made up 1.7 per cent of total TB cases (2017–2023)

How To Control

The CDC report calls for maintaining public health capacity for TB outbreak detection, prevention, and response, even in areas with low TB incidence.

Importantly, they pressed for national genomic surveillance to help prevent and control outbreaks at the local levels.

They also emphasize the need for targeted public health strategies focused on populations at increased risk, particularly those experiencing housing instability, substance use, or incarceration.

What Is Tuberculosis?

Tuberculosis (TB) is a bacterial infection that primarily affects the lungs but can spread to other parts of the body. It is transmitted through the air when an infected person coughs or sneezes. Without proper treatment, TB can be fatal.

What Are The Symptoms?

Persistent cough that lasts more than three weeks

Fever

Night sweats

Unexplained weight loss.

End of Article

India Installs US FDA-approved Portable MRI For Bedside Brain Scans At AIIMS Delhi

Updated May 2, 2026 | 10:00 PM IST

SummaryThe Swoop MRI system, developed by US-based medical technology company Hyperfine, is installed at the AIIMS’ Center for Neurological Conditions. It will enable rapid brain imaging for critically ill patients in ICUs, emergencies, and neurosurgical care.
India Installs US FDA-approved Portable MRI For Bedside Brain Scans At AIIMS Delhi

Credit: Hyperfine Inc

In a significant public health move, the All India Institute of Medical Sciences, New Delhi, has deployed India’s first portable MRI for bedside brain scans, marking an important milestone for neurological care across the country.

The MRI system, installed at the AIIMS’ Center for Neurological Conditions, will enable rapid brain imaging for critically ill patients in ICUs, emergencies, and neurosurgical care.

The ultra-low-field device can be wheeled directly to patients, eliminating the need for dedicated MRI suites or risky patient transfers.

“Bedside brain imaging transforms how we care for our most critically ill patients. At AIIMS, we manage thousands of stroke and ICU patients annually, where rapid neuroimaging is essential—yet transport to conventional MRI is often unsafe or impossible,” said Dr. Shailesh Gaikwad, Head, Department of Neuroimaging and Interventional Neuroradiology and Chief of Neuroscience Centre, AIIMS New Delhi, in a statement.

Bedside MRI: The Swoop system

The Swoop MRI system, developed by US-based medical technology company Hyperfine, is the world's first FDA-cleared, portable, and ultra-low-field magnetic resonance brain imaging system capable of providing imaging at multiple points of care.

It is expected to improve rapid diagnosis in stroke, trauma, ICU monitoring, pediatrics, and post-operative neurosurgical care.

Across the world, portable bedside MRI systems are being used in hospitals in the US, Canada, Australia, the UK, New Zealand, and various EU countries.

“The Swoop system eliminates that barrier. Now our clinicians can obtain diagnostic images at the point of care, enabling faster decision-making in neurology, trauma, and critical care," Dr Gaikwad explained.

Also read: India’s Vaccine Initiatives: HPV For Girls, Indigenous Dengue Shot On The Horizon

He added that as AIIMS Delhi "serves as a referral center across India, this deployment signals what's possible when technology and clinical need align to advance neurological care”.

The technology enables faster decision-making in emergencies, in cases where conventional imaging is difficult or unsafe.

The installation in AIIMS Delhi follows regulatory approval in India, Hyperfine said in a statement.

Experts stated that the development could significantly expand access to brain imaging and strengthen research in point-of-care neurodiagnostics nationwide.

India Installs US FDA-approved Portable MRI For Bedside Brain Scans At AIIMS Delhi

How The Swoop System Is Better Than Conventional MRIs?

Conventional high-field MRI systems require dedicated shielded rooms, specialized infrastructure, and patient transport.

For critically ill patients in ICUs, trauma bays, neurosurgery wards, neonatal units, and emergency departments, transport is often not feasible. These limitations can delay diagnosis and treatment and impact outcomes.

On the other hand, the Swoop system

  • Requires no dedicated room,
  • No specialized power,
  • No patient transfer
  • It can be wheeled to the patient’s bedside in the ICU, trauma center, stroke unit, or neonatal ward and obtain brain images when and where they are needed most.

“Bringing the Swoop system to AIIMS New Delhi is an important milestone following regulatory approval last December. India has a significant unmet need for accessible brain imaging. Deployment at the country’s leading institution signals the start of bringing point-of-care brain MRI to sites of care and institutions across India, where it can serve clinicians and their patients across neurological conditions,” said Maria Sainz, President and CEO of Hyperfine.

The Swoop system deployment at AIIMS New Delhi also establishes a foundation for clinical research. The AIIMS New Delhi team plans to document outcomes, contribute to peer-reviewed publications, and advance India’s role in the growing global evidence base for point-of-care brain imaging.

End of Article